Table 5. Identified gaps or weak overlaps (less than 6 nucleotides) between populations of gRNAs observed in both data sets.
Gene | Stage Missing Coverage | Rangeb | Gap or Overlap | Abundance of Equivalent gRNA |
---|---|---|---|---|
A6 | Bloodstream | 669–670 | 2 nt Gap | 39,063 |
CR3 | BS/Pa | 233/226-230 | 1 nt G/5 nt O | Missing in Both Stages |
CR3 | Procyclic | 278–292 | 15 nt Gap | 125 |
CR4 | Bloodstream | 143–165 | 23 nt Gap | 7,175 |
CR4 | Bloodstream | 302–306 | 5 nt Gap | 643 |
MurfII | BS/P | 80–85 | 6 nt Gap | Missing in Both Stages |
ND3 | BS/P | 389–401 | 13 nt Gap | Missing in Both Stages |
ND7 | BS/P | 92–94 | 3 nt Gap | Missing in Both Stages |
ND7 | Bloodstream | 95–120 | 26 nt Gap | 1 |
ND7 | Bloodstream | 292–293 | 2 nt Overlap | 3,259 |
ND7 | Bloodstream | 325–326 | 2 nt Gap | 888 |
ND7 | BS/P | 485–486 | 0 nt Overlap | Missing in Both Stages |
ND7 | Bloodstream | 1000–1000 | 1 nt Overlap | 101 |
ND7 | Bloodstream | 1079–1085 | 7 nt Gap | 44 |
ND7 | BS/P | 1086/1086-1088 | 1 nt G/3 nt G | Missing in Both Stages |
ND7 | Bloodstream | 1225–1232 | 8 nt Gap | 123 |
ND7 | Bloodstream | 1269–1270 | 2 nt Overlap | 63 |
ND8 | Bloodstream | 54–56 | 3 nt Overlap | 1 |
ND8 | Bloodstream | 153–159 | 7 nt Gap | 4 |
ND8 | Bloodstream | 386–389 | 4 nt Gap | 2 |
ND8 | Procyclic | 541–553 | 13 nt Gap | 413 |
ND9 | Procyclic | 238–242 | 5 nt Overlap | 652 |
ND9 | Bloodstream | 340–342 | 3 nt Gap | 36 |
ND9 | Procyclic | 609–612 | 4 nt Overlap | 7 |
RPS12 | Bloodstream | 122–132 | 11 nt Gap | 3 |
RPS12 | Bloodstream | 156–158 | 3 nt Overlap | 62 |
RPS12 | Bloodstream | 337–349 | 13 nt Gap | 128 |
aIndicates that the region of poor coverage was identified in both data sets.
bRange is respective nucleotides in the fully edited mRNA. Both nucleotides and deletion sites in the fully edited mRNA were numbered starting from the 5’ end (see S2 Fig for numbered sequences).